Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.452,79
-0,69%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Gsk Plc (GSK) Gsk Plc (GSK) Notizie

GSK

Gsk (GSK)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:GSK
DataOraFonteTitoloSimboloCompagnia
03/05/202416:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
01/05/202416:00RNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
01/05/202409:50Alliance NewsAlliance NewsTOP NEWS: GSK expects momentum to continue after strong first quarterLSE:GSKGsk Plc
01/05/202408:00RNS Regulatory NewsGSK PLC 1st Quarter ResultsLSE:GSKGsk Plc
24/04/202410:14Alliance NewsAlliance NewsGSK's Jemperli with chemotherapy accepted for priority review by FDALSE:GSKGsk Plc
24/04/202408:00RNS Regulatory NewsGSK PLC US FDA accepts new indication filing for JemperliLSE:GSKGsk Plc
17/04/202409:46Alliance NewsAlliance NewsTOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatmentLSE:GSKGsk Plc
17/04/202408:05RNS Regulatory NewsGSK PLC GSK announces additional EAGLE-1 resultsLSE:GSKGsk Plc
17/04/202408:00RNS Regulatory NewsGSK PLC Results from long-term data relating to ShingrixLSE:GSKGsk Plc
16/04/202415:11RNS Regulatory NewsGSK PLC Amendment - Director/PDMR ShareholdingLSE:GSKGsk Plc
16/04/202409:59Alliance NewsAlliance NewsGSK's latest meningitis vaccine accepted for review by US regulatorLSE:GSKGsk Plc
16/04/202408:00RNS Regulatory NewsGSK PLC FDA accepts GSK meningitis vaccine candidate fileLSE:GSKGsk Plc
08/04/202411:27Alliance NewsAlliance NewsIN THE KNOW: Barclays ups GSK price target but HIV drug nerves remainLSE:GSKGsk Plc
04/04/202413:05RNS Regulatory NewsGSK PLC Replacement - Total Voting RightsLSE:GSKGsk Plc
25/03/202414:00RNS Regulatory NewsGSK PLC Notice of AGMLSE:GSKGsk Plc
22/03/202417:20RNS Regulatory NewsGSK PLC Transfer of Treasury SharesLSE:GSKGsk Plc
18/03/202410:30RNS Regulatory NewsGSK PLC New Phase III Jemperli data in endometrial cancerLSE:GSKGsk Plc
18/03/202409:47Alliance NewsAlliance NewsGSK says Jemperli combination gets good results for endometrial cancerLSE:GSKGsk Plc
08/03/202418:12RNS Regulatory NewsGSK PLC Board Committee ChangeLSE:GSKGsk Plc
07/03/202410:38Alliance NewsAlliance NewsGSK observes positive data in Blenrep trial for blood cancer treatmentLSE:GSKGsk Plc
07/03/202408:00RNS Regulatory NewsGSK PLC GSK announces positive Blenrep DREAMM-8 resultsLSE:GSKGsk Plc
06/03/202417:00RNS Regulatory NewsGSK PLC ViiV LAI vs oral SOC data in adherence-challengedLSE:GSKGsk Plc
05/03/202418:24RNS Regulatory NewsGSK PLC GSK Annual Report 2023 on Form 20-FLSE:GSKGsk Plc
05/03/202412:03Alliance NewsAlliance NewsGSK says ViiV's cabotegravir study supports longer HIV dose intervalLSE:GSKGsk Plc
05/03/202408:00RNS Regulatory NewsGSK PLC New ViiV LA formulation potential 4-month dosingLSE:GSKGsk Plc
01/03/202413:15RNS Regulatory NewsGSK PLC GSK publishes Annual Report 2023LSE:GSKGsk Plc
29/02/202410:44Alliance NewsAlliance NewsTOP NEWS: GSK avoids "protracted litigation" with Zantac settlementLSE:GSKGsk Plc
29/02/202408:05RNS Regulatory NewsGSK PLC Directorate ChangeLSE:GSKGsk Plc
29/02/202408:00RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
26/02/202409:25Alliance NewsAlliance NewsGSK gonorrhoea treatment achieves efficacy endpoint in latest trialLSE:GSKGsk Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:GSK

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
TRN
Terna Trasmissione Elett...
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network